The melanoma cell lines had various statuses of the most common mutations in BRAF (BRAFV600E) and NRAS (NRASQ61R), but harboured no mutation in the other key components of the PI3K pathway, including PIK3CA, PTEN, and PIB5PA (Figure 1D) [31]. The gene discussed is NRAS; the disease is melanoma.